MAPT and Lewy body dementia: The secondary objectives were to study the relationships between the concentration of CSF α-syn and (i) CSF amyloid and Tau biomarkers, (ii) the main neuroimaging characteristics of these individuals, (iii) the Mild Cognitive Impairment (MCI) or dementia stages, in patients with DLB or AD.